Inolimomab is an anti-interleukin-2 receptor (IL-2R) alpha chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD)[1][2].
Molecular Weight:
(145.34 kDa)
Purity:
98.78
CAS Number:
[152981-31-2]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted